Clinical trial
Safety Assessment of Molecular Hydrogen Inhalation in Patients With Mild Cognitive Impairment
NCT07757542 is registered in ClinicalTrials.gov with University of Ostrava as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety Assessment of Molecular Hydrogen Inhalation in Patients With Mild Cognitive Impairment
- Lead sponsor
- University of Ostrava
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 12, 2026
- Completion date
- October 31, 2027
- Enrollment
- 34 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mild cognitive impairment (mci)